Virtus LifeSci Biotech Products ETF (BBP) Holdings $67.77 +0.06 (+0.09%) Closing price 08/28/2025 04:10 PM EasternExtended Trading$67.68 -0.08 (-0.13%) As of 08/28/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 BBP HoldingsRankCompanyCurrent PriceWeightShares Held1ARDXArdelyx$6.38+3.1%2.70%119,4612RYTMRhythm Pharmaceuticals$104.23+1.9%2.66%7,0523ALNYAlnylam Pharmaceuticals$452.33-0.4%2.53%1,4594AUPHAurinia Pharmaceuticals$12.08-0.2%2.42%53,9975APLSApellis Pharmaceuticals$28.05-0.6%2.36%23,0736MIRMMirum Pharmaceuticals$75.53+1.2%2.32%9,0667TARSTarsus Pharmaceuticals$58.16+0.6%2.27%10,8528LGNDLigand Pharmaceuticals$159.96+0.5%2.26%3,8839INSMInsmed$134.97+0.3%2.25%4,58710MDGLMadrigal Pharmaceuticals$437.17+2.8%2.25%1,495 Get the Latest News and Ratings for BBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Products ETF and its competitors with MarketBeat's FREE daily newsletter. 11HALOHalozyme Therapeutics$72.81-0.5%2.16%8,14812TBPHTheravance Biopharma$13.97+1.2%2.12%41,88413CRSPCRISPR Therapeutics$53.05-0.9%2.11%10,76514BBIOBridgeBio Pharma$52.57+6.0%2.08%11,20815INCYIncyte$83.70-1.3%2.06%6,42016FOLDAmicus Therapeutics$7.65+0.1%2.03%72,02517IONSIonis Pharmaceuticals$42.62-0.3%2.00%12,47618KNSAKiniksa Pharmaceuticals International$33.50-0.6%1.99%16,02619TVTXTravere Therapeutics$17.70+1.5%1.96%29,74520REGNRegeneron Pharmaceuticals$579.61-1.3%1.89%85221ACADACADIA Pharmaceuticals$26.23-1.3%1.88%20,44122ONCBeOne Medicines$297.96-0.7%1.87%1,60723ASNDAscendis Pharma A/S$193.90+0.5%1.86%2,60024HRMYHarmony Biosciences$37.97-0.2%1.84%13,33325AGIOAgios Pharmaceuticals$38.18-2.8%1.82%12,881 Geographic ExposureUnited States88.6%Canada2.4%Switzerland2.1%United Kingdom2.0%Bermuda1.7%Currency ExposureUSD100.0%Sector ExposureHealth Care94.5%Consumer Discretionary2.4%Industry ExposureBiotechnology88.2%Pharmaceuticals6.2%Distributors2.4%SubIndustry ExposureBiotechnology85.8%Pharmaceuticals8.1%Coupon Exposure0-21.1% Related Companies and Tools Related Companies Goldman Sachs Future Health Care Equity ETF Holdings Invesco Nasdaq Biotechnology ETF Holdings Harbor Health Care ETF Holdings Horizon Kinetics Medical ETF Holdings Virtus LifeSci Biotech Clinical Trials ETF Holdings First Trust Nasdaq Pharmaceuticals ETF Holdings T. Rowe Price Health Care ETF Holdings Direxion Daily Pharmaceutical & Medical Bull 3X Shares Holdings Global X HealthTech ETF Holdings JPMorgan Healthcare Leaders ETF Holdings This page (NYSEARCA:BBP) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access